POLYCRYSTALLINE CHALCOGENIDE CERAMIC MATERIAL
2838866 - EP13795886B1 - EPO
Application Apr 15, 2013 - Publication Feb 17, 2021
2838866 - EP13795886B1 - EPO
Application Apr 15, 2013 - Publication Feb 17, 2021
3585688 - EP17719014B1 - EPO
Application Feb 27, 2017 - Publication Feb 17, 2021
2870686 - EP13734038B1 - EPO
Application Jul 01, 2013 - Publication Feb 17, 2021
3773524 - EP19786222A1 - EPO
Application Apr 09, 2019 - Publication Feb 17, 2021
2667002 - EP13168891B1 - EPO
Application May 23, 2013 - Publication Feb 17, 2021
3774938 - EP19718503A1 - EPO
Application Mar 25, 2019 - Publication Feb 17, 2021
2491545 - EP10825595B1 - EPO
Application Oct 20, 2010 - Publication Feb 17, 2021
3773690 - EP19716193A1 - EPO
Application Apr 12, 2019 - Publication Feb 17, 2021
3777946 - EP19191879A1 - EPO
Application Aug 15, 2019 - Publication Feb 17, 2021
Die Erfindung betrifft einen Katheter (1), mit: einem Außenschaft (10), der sich von einem proximalen Endabschnitt (10a) zu einem distalen Endabschnitt des Außenschafts (10) erstreckt und eine Außenseite (10b) aufweist, und einem mit dem proximalen Endabschnitt (10a) des Außenschaftes (10) verbundenen Verbinder (2), der zur Herstellung einer fluidl...
3777885 - EP20185534A1 - EPO
Application Jun 19, 2012 - Publication Feb 17, 2021
The present invention relates to methods and compositions for preventing and treatingStaphylococcus aureusin a subject. Therapeutic compositions of the present invention comprise leukocidin E and/or D proteins or polypeptides and anti-leukocidin E and/or D antibodies. The invention further relates to methods of identifying inhibitors of LukE/D cyto...